• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 4. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 5. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090

Recent Advances in the Study of 2-amino-4-methoxybenzene-1-sulfonamide (CAS: 72106-13-9): A Comprehensive Research Brief

2-amino-4-methoxybenzene-1-sulfonamide (CAS: 72106-13-9) is a sulfonamide derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications. Recent studies have explored its role as a key intermediate in the synthesis of novel bioactive compounds, particularly in the development of antimicrobial and anticancer agents. This research brief aims to provide an overview of the latest findings related to this compound, highlighting its chemical properties, biological activities, and potential applications in drug discovery.

A study published in the Journal of Medicinal Chemistry (2023) investigated the antimicrobial properties of 2-amino-4-methoxybenzene-1-sulfonamide and its derivatives. The researchers synthesized a series of analogs and evaluated their efficacy against a panel of Gram-positive and Gram-negative bacteria. The results demonstrated that certain derivatives exhibited potent inhibitory activity against methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli, with minimal cytotoxicity to human cells. These findings suggest that 2-amino-4-methoxybenzene-1-sulfonamide could serve as a promising scaffold for the development of new antibiotics to combat drug-resistant bacterial infections.

In addition to its antimicrobial potential, 2-amino-4-methoxybenzene-1-sulfonamide has also been explored for its anticancer properties. A recent study in Bioorganic & Medicinal Chemistry Letters (2024) reported that this compound exhibited selective cytotoxicity against several cancer cell lines, including breast cancer (MCF-7) and lung cancer (A549). Mechanistic studies revealed that the compound induced apoptosis via the mitochondrial pathway, accompanied by the activation of caspase-3 and -9. These results underscore the potential of 2-amino-4-methoxybenzene-1-sulfonamide as a lead compound for the development of targeted cancer therapies.

The chemical synthesis and optimization of 2-amino-4-methoxybenzene-1-sulfonamide have also been a focus of recent research. A study in Tetrahedron (2023) described an efficient and scalable synthetic route for this compound, utilizing a one-pot reaction strategy with improved yield and purity. The authors highlighted the importance of optimizing reaction conditions to minimize byproduct formation and enhance the overall efficiency of the synthesis. This advancement is particularly relevant for large-scale production, which is essential for further preclinical and clinical studies.

Furthermore, computational studies have provided insights into the molecular interactions of 2-amino-4-methoxybenzene-1-sulfonamide with biological targets. Molecular docking simulations, as reported in the Journal of Chemical Information and Modeling (2024), identified key binding interactions between the compound and the active sites of bacterial dihydropteroate synthase (DHPS) and human carbonic anhydrase IX (CAIX). These findings not only elucidate the mechanism of action but also guide the rational design of more potent and selective derivatives.

Despite these promising findings, challenges remain in the development of 2-amino-4-methoxybenzene-1-sulfonamide-based therapeutics. Issues such as solubility, bioavailability, and potential off-target effects need to be addressed through further structural modifications and pharmacokinetic studies. Ongoing research is also exploring the combination of this compound with other therapeutic agents to enhance its efficacy and reduce the risk of resistance development.

In conclusion, 2-amino-4-methoxybenzene-1-sulfonamide (CAS: 72106-13-9) represents a versatile and promising scaffold in chemical biology and drug discovery. Recent studies have highlighted its potential as an antimicrobial and anticancer agent, supported by both experimental and computational evidence. Continued research efforts are expected to further elucidate its therapeutic potential and pave the way for the development of novel drugs based on this compound. This research brief underscores the importance of interdisciplinary approaches in advancing the understanding and application of 2-amino-4-methoxybenzene-1-sulfonamide in the pharmaceutical industry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)